Tag: AI regulation

Browse our exclusive articles!

OpenAI CEO’s World Tour to Stay Ahead of Global Regulators

OpenAI CEO Sam Altman is on a global tour to prevent governments from regulating his ChatGPT AI chatbot. While advocating for future regulations, he aims to avoid current oversight efforts. However, his actions have raised concerns about the misuse of AI technology and highlighted the need for an international regulatory framework.

OpenAI CEO Warns Excessive Regulation Could Impede Progress in Artificial Intelligence Development

OpenAI chief Sam Altman warns against heavy regulation hindering AI development, highlighting the need for long-term institutional oversight. His call for global organisation to audit and license AI models comes amid concerns over superintelligence risks and potential automation disruption to industries. Altman's innovative ChatGPT program impresses with its ability to generate essays and poems but critics raise concerns around potential chatbot disinformation.

Herzog meets with OpenAI CEO to discuss risks and regulation

President Herzog of Israel teams up with OpenAI's CEO to promote the safe use of Artificial Intelligence (AI). As AI dominates today's world, this collaboration emphasizes the necessity for ethical considerations. The meeting signified a commitment to AI development that benefits society.

Meeting Between MoS Rajeev Chandrasekhar and OpenAI CEO Sam Altman is Expected.

India's tech minister meets with OpenAI CEO to discuss AI regulation. Will India set a standard for the international community to follow?

OpenAI’s call for AI regulation is tainted by conflict of interest, says Zerodha CTO Kailash Nadh

Kailash Nadh, CTO of Zerodha, discusses the need for AI regulation amidst copyright infringement lawsuits and concerns over lack of transparency in black box models.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img